BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

29 related articles for article (PubMed ID: 37391891)

  • 1. Cell adhesion molecule 1 expression in mycosis fungoides versus parapsoriasis versus inflammatory dermatosis: an immunohistochemical comparative study.
    Neinaa YME; El-Maadawy IH; Atteia IA; Mohamed DAE
    Arch Dermatol Res; 2023 Oct; 315(8):2403-2411. PubMed ID: 36943432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of the phenotype on mycosis fungoides prognosis, a retrospective cohort study of 160 patients.
    Jaque A; Mereniuk A; Walsh S; Shear NH; Sade S; Zagorski B; Alhusayen R
    Int J Dermatol; 2019 Aug; 58(8):933-939. PubMed ID: 30761533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fas ligand expression by neoplastic T lymphocytes mediates elimination of CD8+ cytotoxic T lymphocytes in mycosis fungoides: a potential mechanism of tumor immune escape?
    Ni X; Hazarika P; Zhang C; Talpur R; Duvic M
    Clin Cancer Res; 2001 Sep; 7(9):2682-92. PubMed ID: 11555580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relevance of peripheral blood T-helper 1 and 2 cytokine pattern in the evaluation of patients with mycosis fungoides and Sézary syndrome.
    Papadavid E; Economidou J; Psarra A; Kapsimali V; Mantzana V; Antoniou C; Limas K; Stratigos A; Stavrianeas N; Avgerinou G; Katsambas A
    Br J Dermatol; 2003 Apr; 148(4):709-18. PubMed ID: 12752128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. YKL-40 immunoexpression as a prognosticator of mycosis fungoides.
    Neinaa YME; Elsayed HTI; Alshenawy HA; Gamei MM
    Int J Dermatol; 2023 Sep; 62(9):1147-1153. PubMed ID: 37391891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.
    Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
    J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions.
    Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
    J Am Acad Dermatol; 2014 Feb; 70(2):223.e1-17; quiz 240-2. PubMed ID: 24438970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mycosis fungoides in patients under 20 years of age: report of 7 cases, review of the literature and study of the clinical course.
    Quaglino P; Zaccagna A; Verrone A; Dardano F; Bernengo MG
    Dermatology; 1999; 199(1):8-14. PubMed ID: 10449950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mycosis fungoides: classic disease and variant presentations.
    Howard MS; Smoller BR
    Semin Cutan Med Surg; 2000 Jun; 19(2):91-9. PubMed ID: 10892710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Papular mycosis fungoides: a new clinical variant of early mycosis fungoides.
    Kodama K; Fink-Puches R; Massone C; Kerl H; Cerroni L
    J Am Acad Dermatol; 2005 Apr; 52(4):694-8. PubMed ID: 15793526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Papular mycosis fungoides].
    Brajon D; Bonnet N; Dales JP; Berbis P
    Ann Dermatol Venereol; 2013; 140(6-7):455-8. PubMed ID: 23773745
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.